Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PASSAGE BIO INC.
PASG | US
0.59
USD0.01
1.55%
PASG | US
About PASSAGE BIO INC.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
0.59
Open
0.57
High
0.61
Low
0.56
Passage Bio Inc. a genetic medicines company develops transformative therapies for central nervous system diseases. It develops PBGM01 a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02 a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03 a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company also develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. Passage Bio Inc. has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement and a development services and clinical supply agreement with Catalent Maryland Inc. The company was incorporated in 2017 and is headquartered in Philadelphia Pennsylvania.
View LessPASG | US
Risk
61.5
Sharpe
-0.20
Luna's Score
39/100
Recommendation
Sell
Luna says (PASG | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
59.1%1 month
61.5%3 months
75.3%6 months
80.0%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.41
Debt to equity
0.29
Debt to assets
0.21
Ent. to EBITDA
0.87
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-84.65M
MarketCap
36.35M
MarketCap(USD)
36.35M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-63.55
Short ratio
6.28
Short perc.
3.30
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.14
Range1M
0.19
Range3M
0.61
Volumes: Market Activity
Rel. volume
0.97
Price X volume
139.33K
